RGD Reference Report - Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration.

Authors: Gold, B  Merriam, JE  Zernant, J  Hancox, LS  Taiber, AJ  Gehrs, K  Cramer, K  Neel, J  Bergeron, J  Barile, GR  Smith, RT  Hageman, GS  Dean, M  Allikmets, R  Allikmets, Rando 
Citation: Gold B, etal., Nat Genet. 2006 Apr;38(4):458-62. Epub 2006 Mar 5.
RGD ID: 1600582
Pubmed: PMID:16518403   (View Abstract at PubMed)
PMCID: PMC2921703   (View Article at PubMed Central)
DOI: DOI:10.1038/ng1750   (Journal Full-text)

Age-related macular degeneration (AMD) is the most common form of irreversible blindness in developed countries. Variants in the factor H gene (CFH, also known as HF1), which encodes a major inhibitor of the alternative complement pathway, are associated with the risk for developing AMD. Here we test the hypothesis that variation in genes encoding other regulatory proteins of the same pathway is associated with AMD. We screened factor B (BF) and complement component 2 (C2) genes, located in the major histocompatibility complex class III region, for genetic variation in two independent cohorts comprising approximately 900 individuals with AMD and approximately 400 matched controls. Haplotype analyses identify a statistically significant common risk haplotype (H1) and two protective haplotypes. The L9H variant of BF and the E318D variant of C2 (H10), as well as a variant in intron 10 of C2 and the R32Q variant of BF (H7), confer a significantly reduced risk of AMD (odds ratio = 0.45 and 0.36, respectively). Combined analysis of the C2 and BF haplotypes and CFH variants shows that variation in the two loci can predict the clinical outcome in 74% of the affected individuals and 56% of the controls. These data expand and refine our understanding of the genetic risk for AMD.



RGD Manual Disease Annotations    Click to see Annotation Detail View

  
Object SymbolSpeciesTermQualifierEvidenceWithNotesSourceOriginal Reference(s)
C2Ratmacular degeneration susceptibilityISOC2 (Homo sapiens)DNA:polymorphismRGD 
C2Mousemacular degeneration susceptibilityISOC2 (Homo sapiens)DNA:polymorphismRGD 
C2Humanmacular degeneration susceptibilityIAGP DNA:polymorphismRGD 

Objects Annotated

Genes (Rattus norvegicus)
C2  (complement C2)

Genes (Mus musculus)
C2  (complement C2)

Genes (Homo sapiens)
C2  (complement C2)


Additional Information